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        Tuberculosis is the predominant cause for mortal-
ity from chronic pulmonary bacterial infections 
worldwide causing nearly two million deaths 
yearly. Tuberculosis has become more serious as 
a consequence of the global AIDS epidemic and 
the emergence of multidrug-resistant   Mycobacte-
rium tuberculosis   (  Mtb  ), the causative agent of tu-
berculosis (  1  ). Natural transmission of   Mtb   occurs 
predominantly via inhalation of aerosols contain-
ing small numbers of bacteria that are deposited in 
the distal airways of the lung (  2  ). The pathogens 
are phagocytosed by pulmonary M    , which serve 
as a sanctuary for   Mtb   (  3  ). Virulent   Mtb  , which 
reside in M    , initially evade elimination by the 
immune system via preventing apoptosis and in-
hibiting maturation of the phagosome  –  lysosome 
organelle of the host M     (  4, 5  ). The net eff  ect is 
to diminish entry of bacterial proteins into the class 
II MHC antigen-processing pathway (  4  ) and to 
create a protected intracellular milieu where ba-
cilli remain metabolically active and replication 
competent (  6  ). For M     infected with virulent 
H37Rv, necrosis characterized by cytolysis is the 
dominant form of cell death, which aff  ords a pro-
tective milieu for   Mtb   (  7, 8  ). Thus, subversion of 
cell death toward necrosis is of considerable ad-
vantage for the pathogen. 
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  Virulent   Mycobacterium tuberculosis   (  Mtb  ) induces a maladaptive cytolytic death modality, 
necrosis, which is advantageous for the pathogen. We report that necrosis of macrophages 
infected with the virulent   Mtb   strains H37Rv and Erdmann depends on predominant LXA  4   
production that is part of the antiinfl  ammatory and infl  ammation-resolving action induced 
by   Mtb  . Infection of macrophages with the avirulent H37Ra triggers production of high 
levels of the prostanoid PGE  2  , which promotes protection against mitochondrial inner 
membrane perturbation and necrosis. In contrast to H37Ra infection, PGE  2   production is 
signifi  cantly reduced in H37Rv-infected macrophages. PGE  2   acts by engaging the PGE  2   
receptor EP2, which induces cyclic AMP production and protein kinase A activation. To 
verify a role for PGE  2   in control of bacterial growth, we show that infection of prostaglan-
din E synthase (PGES)      /      macrophages in vitro with H37Rv resulted in signifi  cantly higher 
bacterial burden compared with wild-type macrophages. More importantly, PGES      /      mice 
harbor signifi  cantly higher   Mtb   lung burden 5 wk after low-dose aerosol infection with 
virulent   Mtb  . These in vitro and in vivo data indicate that PGE  2   plays a critical role in 
inhibition of   Mtb   replication. 
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acid (AA) from the sn-2 position of membrane phospho-
lipids (  28  ). AA and its functionally diverse and biologically 
active eicosanoid products have been implicated in the regula-
tion of programmed cell death in several cell types (  29, 30  ). 
The lipoxins are AA metabolites generated by 5- and 15-lipoxy-
genases (5- and 15-LO) (  31  ). Lipoxins modulate chemokine and 
cytokine expression, stimulate monocyte traffi   cking, and en-
hance M     engulfment of apoptotic leucocytes (  32  ). However 
the role of 5-LO products of AA such as lipoxins and leukotri-
ene B  4  , which amplifi  es PMN chemotaxis and production of 
granule products (  33  ), has not been elucidated in modulating the 
death modality of M    . 
  Prostanoids are lipid mediators generated from AA by the 
enzymatic action of the cyclooxygenases (COX) 1 and 2 to 
form the intermediate PGH  2  , with subsequent metabolism to 
specifi  c prostanoid species (e.g., PGD  2  , PGE  2  , PGF  2     , PGI  2  , 
and thromboxane) by prostaglandin synthases (  34, 35  ). The 
functions of these prostanoids are defi  ned by an array of spe-
cifi  c receptors. In the case of PGE  2  , diff  erential expression of 
four distinct EP receptors defi  nes the intracellular pathways 
that are activated by PGE  2   and results in specifi  c functions that 
might either promote or inhibit infl  ammation. For example, 
in the lung, PGE  2   either promotes vasodilatation and increases 
vascular permeability or increases bronchodilatation (  36  ). 
A recent study describes a noninfl  ammatory function of PGE  2  , 
up- or down-regulation of programmed cell death, which in-
dicates that the mechanisms of PGE  2   activation are complex 
and context dependent (  37  ). 
  Mice with a deleted 5-LO gene have increased IL-12, 
IFN-    , and NO synthase 2 levels compared with WT mice 
after pulmonary   Mtb   infection. 5-LO      /      mice also have sig-
nifi  cantly lower   Mtb   burdens and survive longer than WT 
animals after respiratory   Mtb   infection (  38  ). Importantly, ad-
ministration of a stable LXA  4   analogue was suffi   cient to re-
verse the increased resistance of 5-LO      /      mice to   Mtb   infection. 
The fi  nding that   Mtb   infection signifi  cantly increases AA pro-
duction via activation of cPLA  2  -     (  27  ) and that 5 LO      /      
mice are signifi  cantly more resistant to   Mtb   infections (  38  ), 
raised the question of whether eicosanoid production is in-
volved in macrophage necrosis and inhibition of apoptosis 
induced by virulent   Mtb  . We hypothesize that stimulation of 
lipoxin by virulent   Mtb   inhibits macrophage apoptosis, pro-
motes necrosis, and represents a mechanism that allows   Mtb   
to evade elimination by the innate immune system. We there-
fore investigated how lipoxins and prostanoids aff  ect the out-
come of   Mtb  -driven M     death with respect to apoptosis and 
necrosis as a novel pathogenic mechanism that regulates the 
innate immune response in   Mtb   infection. 
    RESULTS   
  Virulent   Mtb   trigger production of LXA  4   in M     
  We demonstrated that inhibition of cPLA  2   abrogates apopto-
sis in   Mtb  -infected M    , which could be restored by reconsti-
tution of AA, the predominant product of cPLA  2   (  27  ). These 
fi  ndings suggest that products synthesized from AA, namely 
the eicosanoids, regulate programmed M     death induced 
  A common mechanism of necrosis is induction of mito-
chondrial permeability transition (MPT), which is manifested 
as accelerated cell death with plasma membrane disintegration. 
It is thought that a pore opens in the inner mitochondrial 
membrane allowing water and other molecules to pass through. 
Opening of this permeability transition pore can be triggered 
by multiple stimuli and leads to dissipation of the mitochondrial 
inner membrane potential (          m  ) (  9  ). Irreversible induction of 
MPT leads to mitochondrial damage associated with mito-
chondrial swelling and subsequent necrosis of the cell. In vitro 
M     infected with virulent H37Rv causes the catastrophic irre-
versible MPT that commits the M     to necrosis (  10  ). 
  The active nature of this necrosis induction by virulent 
  Mtb   is clearly revealed after infection of M     with mutants of 
  Mtb  . Although host M     support growth of virulent   Mtb   (  3  ), 
innate immune mechanisms are activated that limit pathogen 
survival after infection with   Mtb   mutants having altered viru-
lence. These responses include induction of apoptosis, a slow 
cell death modality which leaves the plasma membrane intact 
and is observed after infection of M     with attenuated   Mtb   
(  11  –  13  ). This M     death modality limits exploitation of the 
intracellular growth environment through direct microbici-
dal eff  ects and by sequestering bacilli in apoptotic bodies. Indeed, 
apoptosis both enhances antigen presentation by DC (  14  ) and 
facilitates effi   cient pathogen killing (  15  –  18  ). 
  Two pathways are described that lead to this highly regu-
lated form of cell death (  19  ). First, the extrinsic apoptotic 
pathway implicates binding of the ligands TNF and FasL 
to their receptors that trigger apoptosis (  20  ). Second, the in-
trinsic apoptotic pathway involves the mitochondria, which 
release cytochrome   c   and other factors from the mitochondrial 
intermembrane space that promote apoptosis (  21, 22  ). 
  We demonstrated previously that mitochondria play an es-
sential role to determine whether   Mtb  -infected M     undergo 
cytolytic necrosis or apoptosis (  8  ). Apoptosis induced by the 
mitochondrial pathway commences with Ca  2+   release from the 
ER that leads to an increase of Ca  2+   in the mitochondria as 
well as translocation of BAX into the mitochondria and BAK 
activation (  23  ). Permeabilization of the mitochondrial outer 
membrane then proceeds via formation of a proteolipid pore 
and subsequent escape of proteins from the mitochondrial in-
termembrane space into the cytosol. More specifi  cally, upon 
mitochondrial outer membrane permeabilization proapoptotic 
factors, including cytochrome   c  , are released from the mito-
chondrial intermembrane space into the cytosol. There, cyto-
chrome   c   forms a complex with Apaf-1, leading to activation 
of caspase-9 that, in turn, activates executioner caspases such as 
caspase-3, -6, and -7, which are instrumental in the induction 
of apoptosis (  19, 24  ).   
  Infection with the attenuated   Mtb   H37Ra, which has a 
mutation in PhoP which inhibits ESX-1 function (  25  ), pre-
dominantly prevents necrosis and leads to sequestration and 
decimation of the intracellular bacteria (  8, 26  ).   
    Mtb  -induced apoptosis and antimycobacterial activity of 
human M     requires the activity of cPLA  2  -    , a group IV cyto-
solic PLA  2   (cPLA  2  ) (  27  ) which catalyzes the release of arachidonic JEM VOL. 205, November 24, 2008 
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The production of LXA  4   was measured over time in superna-
tants from M     infected with virulent and avirulent   Mtb  . Viru-
lent H37Rv induce signifi  cantly higher levels of LXA  4   production 
(1 nM;   Fig. 1 B  ). Similar results are observed with another vir-
ulent strain (Erdmann strain [not depicted]). In contrast, when 
M     are infected with avirulent H37Ra, production of LXA  4   
reaches     0.4 nM at 4 and 6 h after infection but is then subse-
quently down-regulated to     0.2 nM at 12 h. The amount of 
LXA  4   production induced by H37Rv correlates with the mul-
tiplicity of infection (MOI;   Fig. 1 C  ). In contrast, the amount 
of LXA  4   production after H37Ra infection was not increased 
when the MOI was raised. 
  These fi  ndings raised the question of whether M     infected 
with virulent   Mtb   negatively regulate COX2 expression. 
Infection of M     with the virulent H37Rv induced little ac-
cumulation of COX2 mRNA and COX2 protein compared 
with infection with the mutant   Mtb   strain H37Ra, suggesting 
that H37Rv infection inhibits COX2 expression (  Fig. 1, D 
and E  ). These fi  ndings suggest that infection with virulent   Mtb   
induces the production of LXA  4   in suffi   cient quantities to in-
hibit COX2 production, which represents an important mani-
festation of bacterial virulence. 
  The virulent   Mtb   strain H37Rv inhibits prostanoid 
production by the host M     
  COX2, the inducible PGH synthase, is required for prostanoid 
synthesis (  40  ). To study whether inhibition of COX2 expression 
by H37Rv had any functional consequences, we measured pros-
tanoid production by   Mtb  -infected M    . PGE  2   levels of   <  1 nM 
were detected in supernatants of H37Rv-infected M     during 
the fi  rst 48 h of infection. In contrast, levels of PGE  2   were pro-
duced by M     infected with H37Ra, which increased over time 
and could be correlated with the MOI (  Fig. 2, A and B  ).   Infec-
tion with H37Ra also signifi  cantly induced production of the 
prostanoids PGF  2      (  Fig. 2 C  ) and TXA  2   (not depicted). In con-
trast, the virulent   Mtb   strain H37Rv failed to induce signifi  cant 
prostanoid production (  Fig. 2, A  –  C  ). To determine whether 
these fi  ndings were not confounded by altered bacterial uptake, 
survival, or replication, we measured bacterial counts. 72 h after 
infection, the bacterial burden was similar between M     infected 
with H37Rv and H37Ra (unpublished data). 
  Thus, virulent   Mtb   suppress COX2 expression in infected 
M    , which leads to a global inhibition of prostanoid produc-
tion. Although prostanoid synthesis is signifi  cantly inhibited by 
H37Rv, the amount that is produced is likely to be an impor-
tant counterbalance to LXA  4   because M     exposed to 1 nM 
LXA  4   are highly sensitive to PGE  2   and respond to     1  –  2 logs 
lower PGE  2   concentrations than M     not exposed to LXA  4   
with a protective response against necrosis (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20080767/DC1). 
  PGE  2   suppresses mitochondrial inner membrane 
perturbation (MPT) and necrosis in M     infected 
with virulent   Mtb   
  Virulent H37Rv induce rampant necrosis. In contrast, avirulent 
H37Ra fail to induce M     necrosis (  7, 8, 12  ). The observation 
by   Mtb  . Two groups of eicosanoids are of special interest 
because of their opposing eff  ects, the prostanoids that are 
derived by the COX pathway (  34  ) and the lipoxins, a distinct 
class of LO-derived products which promote termination of 
infl  ammation (  39  ). 
  The identifi  cation of PGE  2   and LXA  4   in infected M     su-
pernatants was established from the diagnostic ions present in 
their liquid chromatography tandem mass spectrometry (LC-
MS-MS) spectra (  Fig. 1 A  ).   We extended these studies by per-
forming ELISA assays on H37Rv- and H37Ra-infected M    . 
    Figure 1.         LXA  4   and COX2 production of human M     infected with 
H37Rv and H37Ra.   (A) LC-MS-MS of endogenous PGE  2   (top) and LXA  4  
(bottom) produced by H37Ra- (MOI 10) and H37Rv- (MOI 10) infected 
human M    , respectively, at 24 h. The spectrum is a representative LC-MS-
MS (  n   = 3). The prominent ions and relative intensity matched with au-
thentic PGE  2   and LXA  4   under these LC-MS-MS conditions. (B) LXA  4  
production in human M     infected with H37Rv and H37Ra (MOI 10:1) at 
0  –  48 h. Differences in LXA  4   concentrations in supernatants from H37Ra- 
and H37Rv-infected M     are statistically signifi  cant (*, P   <   0.002;   n   =  3). 
(C) LXA  4   accumulation at 48 h in M     supernatants infected with H37Ra 
and H37Rv (MOI 2, 5, and 10:1). The differences in LXA  4   production  in-
duced by H37Ra and H37Rv are statistically signifi  cant at all MOIs (P   <   
0.01;   n   = 3). (D) COX2 mRNA accumulation in M     infected with H37Ra or 
H37Rv (MOI 10:1; uninfect, uninfected). (E) Production of COX2 protein in 
M     infected with H37Ra and H37Rv (MOI 10:1) at different time points. 
In all studies, n represents the number of independent experiments and 
the error bars represent SE. Black lines indicate that intervening lanes 
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cated in experiments with mouse M     (unpublished data). 
Addition of exogenous PGE  2   also inhibited necrosis measured 
by 7-AAD staining of H37Rv-infected M    . Specifi  cally, 
addition of 1   μ  M PGE  2   to H37Rv-infected M     decreased the 
number of 7-AAD  –  positive M     after 48 h from 29   ±   1 to 17   ±   
1% after infection with H37Rv (background 2.2   ±   0.5%; MOI 
10:1; P   <   0.01;   n   = 3). Other prostanoids, such as PGD  2  , 
PGF  2     , PGI  2  , and TXA  2  , and leukotriene LTB  4  , had little or 
no eff  ect on prevention of necrosis (  Fig. 3 C  ). 
  We next confi  rmed the role of PGE  2   in protection against 
  Mtb   infection-induced necrosis using a loss-of-function ap-
proach. In this study, we reasoned that   Mtb  -induced PGE  2   pro-
duction is a default pathway for the innate immune response, 
which may be interrupted in H37Rv infection. Thus, infection 
that infection of M     with H37Rv induces LXA  4   and inhibits 
COX2 and prostanoid production, whereas H37Ra infection 
fails to induce LXA  4   but stimulates COX2 and prostanoid 
production, led to the hypothesis that H37Rv-induced LXA  4   
production may foster M     necrosis via inhibition of PGE  2   
production. Conversely, H37Ra infection may stimulate PGE  2  -
mediated inhibition of LXA  4   and prevent M     necrosis. By 
determining the release of the cationic dye DiCO  6  (3) from 
mitochondria, a correlate of M     necrosis (  41  ), we fi  rst inves-
tigated whether prostanoids block induction of H37Rv-in-
duced necrosis. Indeed, increasing micromolar concentrations 
of PGE  2   signifi  cantly decreased cationic dye release from the 
mitochondria of human M     infected with virulent H37Rv 
(MOI 10) after 24 h (  Fig. 3, A  –  C  ).   These results were dupli-
    Figure 2.         Prostanoid production of M     infected with   Mtb  .   (A)  PGE 2  
production of human M     0  –  48 h after infection with H37Ra and H37Rv 
(MOI 10:1). Differences in PGE  2   concentrations in supernatants from 
H37Ra- and H37Rv-infected M     are statistically signifi  cant (*, P   <   0.002; 
  n   = 3). (B) PGE  2   production by M     infected with H37Ra and H37Rv (MOI 
2:1  –  10:1). The differences in PGE  2   production induced by H37Ra in com-
parison to H37Rv are statistically signifi  cant at all MOIs (*, P   <   0.01;   n   =  3). 
(C) Quantifi  cation of PGE  2 ,  PGF 2     , and PGD  2   in 48-h supernatants from 
human M     (5   ×   10 6   /ml) infected with H37Ra and H37Rv (MOI 10:1; *, 
P   <   0.002;   n   = 4). Data are presented as means   ±   SE. In all studies,   n   repre-
sents the number of independent experiments.     
    Figure 3.         Effect of exogenous prostanoids produced by   Mtb  -in-
fected M     on H37Rv-induced mitochondrial cationic dye release.  
(A) PGE  2   blocks  DiOC 6  (3) release from mitochondria of human M     in-
fected with H37Rv (MOI 5:1; 48 h). A fl  uorescence-activated cell sorter 
diagram is shown. (B) Down-regulation of cationic dye release by increasing 
concentrations of PGE  2   (2 – 10   μ M)  is  statistically  signifi  cant at all PGE  2  
concentrations (P   <   0.01;   n   = 6). (C) Effect of 1   μ  M of various prostanoids 
on H37Rv-induced mitochondrial DiOC  6  (3) release of M    . Only PGE  2   inhibition 
of cationic dye release from the mitochondria is statistically signifi  cant 
(*, P   <   0.007;   n   = 3). PGF  2      has borderline activity. The concentration of 
LTB  4   is 0.1   μ  M. (D) H37Ra (MOI 5:1)-induced DiOC  6  (3) release from mito-
chondria of WT and PGES     /     mouse  M    infected in the absence and 
presence of 1   μ  M PGE  2  . At 48 h, cationic dye release from the mitochon-
dria was measured (*, P   <   0.006;   n   = 5). (E) 1   μ  M PGE  2   does not alter 
H37Ra- and H37Rv-induced cytochrome   c   release from the mitochondria 
(not signifi  cant;   n   = 3). Data are presented as means   ±   SE. In all studies, 
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analogue added to H37Ra-infected M     dramatically inhib-
ited both COX2 protein and PGE  2   production induced by 
H37Ra (  Fig. 4 B  ). Silencing of the 5-LO gene (  Fig. 4 C  , left) 
in M     infected with the virulent H37Rv inhibited H37Rv-
induced LXA  4   production (  Fig. 4 C  , right) and reduced ne-
crosis (  Fig. 4 D  ), demonstrating that 5-LO activity is required 
for LXA  4   production by H37Rv-infected M    . Finally, in-
hibition of LXA  4   synthesis in H37Rv-infected M     by 5-LO 
gene silencing led to PGE  2   production (  Fig. 4 E  ). These re-
sults not only provide additional proof that LXA  4   suppresses 
PGE  2   production but demonstrate that the induction of 
of microsomal prostaglandin E synthase (mPGES)      /      M     de-
fi  cient of PGE  2   production with H37Ra should mimic the vir-
ulent status in H37Rv infection and stimulate necrosis. As 
anticipated, PGES      /      M     (  42  ) are unable to produce PGE  2   
after infection with avirulent H37Ra and show a concomitant 
phenotypic switch to susceptibility to necrosis after infection 
(  Fig. 3 D  ). These results demonstrate that PGES activity in-
hibits   Mtb  -induced necrosis. Addition of exogenous PGE  2   to 
H37Ra-infected PGES      /      M     restored the avirulent pheno-
type with striking inhibition of necrosis and confi  rms that PGE  2   
is a central mediator in cell death regulation of   Mtb  -infected 
M     (  Fig. 3 D  ). 
  To ascertain that induction of human and mouse M     necro-
sis by   Mtb   is caused by related mechanisms, we determined the 
amount of necrosis after infection with the same MOIs of H37Ra 
or H37Rv. The results show that both human and mouse M     
have a similar necrosis response after infection (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20080767/DC1). 
  Defi  ning the existence of distinct mechanisms that regulate 
necrosis and apoptosis, and having observed a PGE  2  -dependent 
modulation in the context of   Mtb   infection, we next investigated 
whether PGE  2   has a direct role in the regulation of M     apopto-
sis. In this study, we assessed PGE  2  -stimulated cytochrome   c   
release from the mitochondrial intermembrane space (  19  ), a 
correlate of apoptosis. Interestingly, we fi  nd that PGE  2   does not 
modulate cytochrome   c   release in H37Ra or H37Rv-infected 
M     (  Fig. 3 E  ), nor does it cause cytochrome   c   release in absence 
of infection (not depicted). Thus, PGE  2   plays no role in the in-
duction of apoptosis. 
  Necrosis is positively regulated by LXA  4   through inhibition 
of prostanoid synthesis leading to mitochondrial inner 
membrane perturbation 
  In the mouse model of   Mtb   infection, LXA  4   production cor-
relates with reduced resistance against   Mtb   (  38  ). Our data re-
veal a relationship between LXA  4   production and M     necrosis 
after virulent   Mtb   infection in vitro. These observations col-
lectively suggest a functional contribution for LXA  4   in the in-
duction of necrosis. We reasoned that if LXA  4   production is a 
mechanism by which virulent H37Rv promote necrosis in in-
fected M    , addition of LXA  4   to M     infected with nonvirulent 
H37Ra should confer a virulent phenotype with regard to 
  Mtb  -induced necrosis. Indeed, LXA  4   signifi  cantly enhanced 
cationic dye release from the mitochondria, a correlate of ne-
crosis, in H37Ra-infected M     (  Fig. 4 A  , left).   Importantly, 
LXA  4   administration in the absence of   Mtb   infection has no 
eff  ect on M     necrosis (  Fig. 4 A  , left). Moreover, addition of 
LXA  4   to H37Ra-infected PGES      /      M    , which are unable to 
synthesize PGE  2  , does not increase cationic dye release from 
the mitochondria (  Fig. 4 A  , right). These results suggest that in 
  Mtb  -infected M    , LXA  4   acts by down-regulating PGE  2   syn-
thesis to induce necrosis. 
  To investigate whether induction of necrosis by LXA  4   is 
based on an inhibitory eff  ect of LXA  4   on PGE  2   synthesis, we 
determined whether LXA  4   blocks synthesis of COX2, thus 
inhibiting generation of PGE  2  . Indeed, 10      9   M of stable LXA  4   
    Figure 4.         Effect of LXA  4   on   Mtb  -infected M    .   (A, left) addition of 
10     9   M  LXA 4   to H37Ra-infected human M     (MOI 10:1) enhances mito-
chondrial cationic dye release (*, statistically signifi  cant difference;   n   =  3; 
P = 0.04). (A, right) LXA  4   by itself is ineffective. Addition of 10     9   and  10    10  
M LXA  4   to  PGES    /     mouse  M    infected with H37Ra (MOI 5:1) does not 
affect mitochondrial cationic dye release (not signifi  cant;   n   =  3). 
(B, left) Production of COX2 protein by H37Ra (MOI 10:1)-infected M     is 
inhibited by the addition of 10     9   M LXA  4  . Western analysis of M     extracts. 
The actions of LXA  4   were mimicked by its metabolic stable analogue (not 
depicted). (B, right) PGE  2   production by M     (*, P   <   0.001;   n   = 3). Black 
lines indicate that intervening lanes have been spliced out. (C and D) Tar-
geted silencing (t) of the 5-LO gene (C,     70% inhibition at t 50) abro-
gates production of LXA  4   by  H37Rv-infected  M    compared  with 
nontargeted (nt) silencing (D, left, 50 nM siRNA; P = 0.001;   n   = 3) and 
reduces mitochondrial cationic dye release after H37Rv infection (D, right; 
nt, nontargeted; P   <   0.04;   n   = 3). Black lines indicate that intervening 
lanes have been spliced out. (E) Targeted silencing of the 5-LO gene re-
constitutes production of PGE  2   after infection of M     with H37Rv, indicat-
ing that block of PGE  2   production is caused by the action of LXA  4   (P   <  
0.003;   n   = 3). Data are presented as means   ±   SE. In all studies,   n   repre-
sents the number of independent experiments (*, statistically signifi   cant).   2796 LIPID MEDIATORS IN   MTB   INFECTION   | Chen et al. 
  Pulmonary   Mtb   infection in mice is controlled by PGE  2   
  The fi  ndings presented in the previous section indicate that 
infection with virulent   Mtb   leads to the induction of LXA  4   
and suppression of PGE  2  , which results in the necrotic death 
of infected M    . We therefore performed in vitro experi-
ments with M     from WT and PGES      /      mice.   Fig. 6 A   
shows that after 4 d of H37Rv infection, the bacterial growth 
was comparable between WT and PGES      /      M    .   However, 
7 d after infection the bacterial burden was signifi  cantly 
higher in PGES      /      M     than in WT M    . These data sug-
gested that PGE  2   plays a major regulatory role in controlling 
bacterial growth in M     and predicted that an alteration in 
the balance between PGE  2   and LXA  4   might change the 
in vivo outcome of infection. Indeed, 5-LO      /      mice are more 
LXA  4   by   Mtb   is a potential mechanism that prevents PGE  2   
production and leads to cell necrosis. 
  The prostanoid receptor EP2 is involved in protection 
of the mitochondrial inner membrane of   Mtb  -infected 
M     by PGE  2   
  The action of PGE  2   on the M     is mediated by four distinct 
G protein  –  coupled E prostanoid (EP) receptors, referred to 
as EP1, EP2, EP3, and EP4 (  43  ), and mice defi  cient in the 
four PGE  2   receptors have been generated (  44  –  47  ). All four 
receptors are expressed by human M     (  Fig. 5 A  ).   The EP1 
receptor is functionally connected to Gq, a G protein that 
increases Ca  2+    i  . The EP2 and EP4 receptors activate G pro-
teins that activate adenylate cyclase leading to increased 
cAMP production. The EP3 receptor inhibits adenylate cy-
clase via Gi and reduces cAMP levels. To confi  rm the cen-
tral role of PGE  2   and to more precisely determine its action 
via specifi  c EP receptors in protection of the mitochondrial 
inner membrane from MPT, we determined the eff  ect of 
exogenous PGE  2   on cationic dye release in WT M     and 
M     from homozygote EP1, EP2, EP3, and EP4      /      mice 
infected with H37Ra and H37Rv. M     from WT, EP1, 
EP3, and EP4      /      mice responded to increasing exogenous 
PGE  2   concentrations with enhanced inhibition of cationic 
dye release induced by H37Rv. Cationic dye release from 
the mitochondria in EP2      /      M     infected with H37Rv 
could not be inhibited even by high concentrations of PGE  2  , 
indicating that EP2 is the major PGE  2   receptor responsible 
for inhibition of mitochondrial cationic dye release. Identi-
cal results were obtained when the cells were infected with 
H37Ra (  Fig. 5 B  ). 
  Stimulation of EP2 and EP4 receptors triggers activation 
of adenylate cyclase (  48  ). EP2 is associated with activation 
of protein kinase A (PKA) (  49  –  51  ). In contrast, signaling 
through EP4 mainly stimulates phosphatidylinositol-3 kinase 
(PI3K)  –  mediated processes (  49, 52  ). To confi  rm that the 
inhibition of mitochondrial cationic dye release is modu-
lated by stimulation of EP2, we examined the eff  ect of the 
specifi  c PKA inhibitor KT5720 (  53  ) on PGE  2  -dependent 
inhibition of mitochondrial cationic dye release. We also 
confi  rmed lack of involvement of the EP4-stimulated PI3K 
pathway by testing the eff  ect of the PI3K inhibitor LY294002 
on mitochondrial cationic dye release (  54  ). KT5720, at 
concentrations previously shown to protect cells from apop-
tosis (10      7   M [reference   53  ]), abrogated the protective ef-
fect of PGE  2   on M     (  Fig. 5 C  ). In agreement with the 
postulated hypothesis that H37Ra is unable to induce ne-
crosis in infected M     because of induction of PGE  2   produc-
tion, addition of KT5720 to H37Ra-infected M    signifi  cantly 
augmented M     necrosis (  Fig. 5 C  ). In contrast, LY294002 had 
no eff  ect (  Fig. 5 D  ). KT5720 and LY294002 alone had no 
eff  ect on mitochondrial cationic dye release induced by H37Rv. 
These results are consistent with a mechanism wherein EP2 
activation of PKA, rather than EP4 activation of PI3K, me-
diates the protective eff  ect of PGE  2   on mitochondria of   Mtb  -
infected M    . 
    Figure 5.         EP2 mediates PGE  2  -dependent protection against cat-
ionic mitochondrial dye release.   Data are presented as means   ±   SE. 
(A) EP1, EP2, EP3, and EP4 are constitutively expressed in human M   . 
Their expression is not increased by either H37Ra or H37Rv infection. 
(B) EP2     /     M    fail to respond to PGE  2   by down-regulating DiCO  6 (3)  re-
lease from the mitochondria infected with H37Rv (top) or with H37Ra 
(bottom), indicating that EP2 mediates the protective function of PGE  2 . 
M     from EP1, EP3, and EP4      /     mice were equally responsive to 1   μ  M 
PGE  2   (*, statistically signifi  cant; P   <   0.01;   n   = 5). (C) The cAMP-dependent 
PKA inhibitor KT5720 abrogates inhibition of mitochondrial cationic dye 
release by PGE  2   (black columns; P   <   0.01;   n   = 3). Addition of KT5720 to 
H37Ra-infected (MOI 10:1) M     enhanced  M    necrosis (gray columns; *, 
P   <   0.01;   n   = 3). (D) The PI3K inhibitor LY294002 does not abrogate inhibi-
tion of mitochondrial cationic dye release by PGE  2   (not signifi  cant;   n   =  3). 
In all studies,   n   represents the number of independent experiments.     JEM VOL. 205, November 24, 2008 
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Our results demonstrate hitherto unappreciated disparate roles 
for LXA  4   and PGE  2   in the regulation of induction of host M     
necrosis, a cell death leading to cytolysis. M     infected with 
virulent   Mtb   that produce LXA  4   and reduced amounts of PGE  2   
undergo necrosis. In contrast, prevention of necrosis and con-
comitant induction of M     apoptosis is associated with in-
creased PGE  2   production. Thus, the induction of LXA  4   and 
the resulting inhibition of PGE  2   production contribute to the 
virulence of   Mtb   and enhance its capacity to evade killing by 
the innate immune system. Indeed, the failure of PGES      /      
M     to control H37Rv replication in vitro and the observation 
that PGES      /      mice have a 10-fold higher   Mtb   burden in their 
lungs compared with WT mice demonstrate the protective ef-
fect of PGE  2   against virulent   Mtb  . Preferential synthesis of ei-
ther LXA  4   or of prostanoids is a critical branch point for the 
innate antimycobacterial response of the infected M     (  Fig. 7  ).   
  Lipoxins are best described as potent negative regulators of 
acute infl  ammatory processes (  55  ), in part via inhibition of DC 
mobilization, inhibition of IL12 production (  56  ), and PMN-
induced infl  ammation in vivo. LXA  4   activities are multifold 
and include inhibition of PMN entry to sites of infl  ammation, 
reduction of vascular permeability, promotion of monocyte 
infi  ltration, and ingestion of apoptotic cells, perhaps including 
infected M     by phagocytes (  39  ). Moreover, lipid mediators 
that resolve infl  ammatory events, including LXA  4  , stimulate 
phagocytosis of zymosan and of microbial organisms leading to 
de novo infection of phagocytes (  56  ). The results suggest that 
the action of LXA  4   in reducing prostanoid production as part 
of the infl  ammation-resolving program of LXA  4   is exploited 
by   Mtb   in the local environment. Thus, although temporally 
regulated dampening of the infl  ammatory response is generally 
highly benefi  cial to the host, our studies uncover a novel sce-
nario wherein LXA  4  -driven reduction of   “  proinfl  ammatory  ”   
PGE  2   synthesis functionally acts as an effi   cient mechanism used 
by pathogenic   Mtb  . More specifi  cally, LXA  4   counteracts the 
resistant to infection (  38  ). Similarly, we would predict that 
in the absence of PGES, mice are more susceptible to infec-
tion. WT and PGES      /      mice were infected by the aerosol 
route with 100 virulent   Mtb   per lung. Similar numbers of 
bacteria were found in the lungs of both WT and PGES      /      
mice on day 1 after infection (  n   = 4/group). The bacterial 
burden in WT and PGES      /      mice was not diff  erent 2 wk 
after infection (unpublished data). However, after 5 wk WT 
mice controlled the infection more effi   ciently compared 
with the PGES      /      mice, whose lungs contained more bac-
teria (     log 10 = 0.97; P = 0.0079;   Fig. 6  ). This diff  erence 
was not observed in the spleen (unpublished data). To assess 
whether the balance between PGE  2   and LXA  4   is changed 
during the course of a mycobacterial infection in vivo, we 
next measured the levels of PGE  2   and LXA  4   in sera from 
WT mice infected with either virulent Erdmann strain or 
avirulent H37Ra. As it was observed in vitro, virulent bac-
teria induced remarkably more LXA  4   after 7 d of infection, 
whereas avirulent H37Ra induced more PGE  2  . This indi-
cates that PGE  2   signifi  cantly contributes in vivo to protec-
tive responses against mycobacterial infection in the lung. 
    DISCUSSION   
  The central fi  nding of this study is that in the local environ-
ment of an   Mtb   infection, M     infected with virulent   Mtb   pref-
erentially synthesize LXA  4   and little, if any, PGE  2  . In contrast, 
M     infected with avirulent H37Ra produce mainly pros-
tanoids, including PGE  2  , and only small amounts of LXA  4  . 
    Figure 6.         Mycobacterial burden of PGES      /      and WT M     in vitro 
and in vivo.   (A) Mycobacterial burden after 4 h (inoculum), 4 d, and 7 d 
of PGES     /     and WT M     in vitro infected with H37Rv (MOI 10:1). The dif-
ference in the bacterial burden was signifi  cant at 4 and 7 d after infection 
(*, P   <   0.03). (B) 5 wk after aerosol infection, CFUs were determined by 
plating of homogenized lung tissue as indicated on the ordinate. The 
difference in mycobacterial burden in the lungs of PGES     /     versus  WT 
mice is statistically signifi  cant (*, P = 0.002; fi  ve mice per group). 
(C and D) Induction of LXA  4   and  PGE 2   production during the course of 
mycobacterial infection. WT mice were infected by aerosol exposure with 
virulent (Erdmann) or avirulent (H37Ra). LXA  4   (C) and PGE  2   (D)  measured 
by ELISA in the sera at 7, 14, and 35 d after infection (*, P   <   0.01; three 
mice per time points). These results are representative of two independent 
experiments. The error bars represent SE.     
    Figure 7.         Infection of M     with the virulent H37Rv predominantly 
induces LXA  4   production and block of COX2 and PGE  2   production, 
which might lead to necrotic cell lysis and spread of the infection.  
In contrast, M     infected with avirulent H37Ra produce larger amounts of 
PGE  2   which blocks LXA  4   production and supports M     apoptosis and con-
tainment of the   Mtb.   Predominant production of either PGE  2   or  LXA 4   by 
M     infected with H37Ra or H37Rv, respectively, is supported by the fact 
that PGE  2   inhibits  LXA 4   production and vice versa.     2798 LIPID MEDIATORS IN   MTB   INFECTION   | Chen et al. 
is the predominant death modality of the host M     infected 
with attenuated   Mtb   including H37Ra and secA2 mutants 
(  13  ). Apoptotic bodies are thought to provide a containment 
vessel for the bacilli as well as an effi   cient means for pathogen 
killing (  15  ). Moreover, apoptotic bodies express specifi  c cell 
surface receptors (  61  ) that promote uptake and subsequent 
antigen presentation to DC (  14  ). Virulent   Mtb   subvert apop-
tosis and induce plasma membrane lysis (necrosis), leading to 
dissipation of the pathogens and spread of the infection. 
  Thus, the fate of the infected M     with regard to cell death 
modality is a critical determinant in an eff  ective host defense 
response to   Mtb   infection. Our studies identify a novel mech-
anism wherein   Mtb   stimulates a pathway involved in the local 
resolution of infl  ammation to subvert defense mechanisms 
against   Mtb  . To our knowledge, this is the fi  rst example of a 
pathway important in the resolution of infl  ammation that is 
targeted by a pathogen to counteract the innate immune sys-
tem. Although it is tempting to advocate therapeutic targets 
of the lipoxin pathway for   Mtb   infection, further studies are 
required both to understand the mechanisms by which LXA  4   
production is activated via virulent   Mtb   and to determine the 
consequences of blocking the LXA  4   production in the course 
of an infection of M     with   Mtb   for the host. 
  MATERIALS AND METHODS 
  Materials.     LY294002, KT5720, and propidium iodide (PI) were obtained 
from Sigma-Aldrich. DiOC  6  (3) (3,3    -dihexyloxycarbocyanine iodide), rhoda-
mine-2 AM, goat anti  –  mouse IgG  1  , and anti  –  mouse COX1 antibodies were 
obtained from Invitrogen. PGE  2  , PGF  2     , PGD  2  , PGI  2  , LTB  4  , TXB  2  , and 
LXA  4  , sheep anti  –  15-LO antibody, and mouse anti-COX2 antibody were ob-
tained from Cayman Chemical. 15-epi-16-phenoxy-parafl  uoro-LXA  4  -methyl 
ester was a gift from Bayer-Schering Pharma AG. Anti  –    	  -actin mAb was ob-
tained from Thermo Fisher Scientifi  c. Mouse anti  –  5-LO antibody, mouse 
IgG  1  , and mouse anti  –  cytochrome   c   mAb (7H8.2C12.6H2.B4) were obtained 
from BD. IMDM, RPMI-1640, Opti-MEM I reduced serum medium, Oligo-
fectamine, Hepes, and DTT were obtained from Invitrogen. Rabbit anti  –
  annexin-1 polyclonal antibody, goat anti  –  rabbit IgG FITC conjugate, 
and HRP protein A were obtained from Invitrogen. Anti  –  phosphatidyl-serine 
mouse mAb (clone1H6) and rabbit IgG were obtained from Millipore. 
  Mice.    6  –  10-wk-old C57BL/6 mice were obtained from Jackson Immuno-
Research Laboratories. mPGES-1      /      mice (N5 backcross onto the C57BL/6 
background, 45) and EP1 (Ep1      /     ; reference   47  ), EP2      /      (  48  ), EP3      /      
(  47  ), and EP4      /      mice (  51  ) (  n     >   10 on C57BL/6 background, provided by 
B. Koller, University of North Carolina, Chapel Hill, NC) were bred locally. 
All procedures were approved by the Dana-Farber Cancer Institute Institu-
tional Animal Care and Use Committee. 
  Bacteria.     The virulent   Mtb   strain H37Rv and the attenuated H37Ra (Amer-
ican Type Culture Collection), prepared as described previously (  8  ), were 
used in the in vitro experiments. The strains were grown in Middlebrook 7H9 
broth (BD) with BBL Middlebrook OADC Enrichment (BD) and 0.05% 
Tween 80 (BD) and resuspended in 7H9 broth at 5   ×   10   7   CFU/ml. Aggrega-
tion was prevented by sonication for 10 s. The bacteria were allowed to settle 
for 10 min. Bacteria in M     were quantifi  ed by lysis of the cells with 0.2% SDS 
in PBS. After neutralization of SDS with 50% FCS, 100   μ  l of cell lysates of 
triplicate cultures were serially diluted 10-fold, plated on 7H10 agar plates 
(Remel), and colonies were counted after 21 d. Alternatively, the pooled cell 
lysates were inoculated into triplicate Bactec 12B vials. The number of bacte-
ria was determined with the Bactec model 460 TB system (BD). 
protective eff  ects of PGE  2   by inhibiting COX2 expression, 
thereby causing necrosis in   Mtb  -infected M    . Interestingly, 
LXA  4   on its own does not induce necrosis, indicating that 
the main function of LXA  4   is down-regulation of prostanoid 
production followed by mitochondrial inner membrane de-
stabilization. These results are consistent with studies demon-
strating that mycobacterial burden is signifi  cantly reduced in 
5-LO      /      mice in comparison to WT mice (  38  ) and suggest 
that LXA  4   negatively regulates antimycobacterial defense re-
sponses. It should be noted that the concentrations of LXA  4   
produced are not suffi   cient to aff  ect infl  ammatory events in 
other experimental systems, a feature which is almost certain 
to be benefi  cial to the   Mtb   pathogen. Consequently,   Mtb   is 
able to escape from the necrotic M     without adverse eff  ects 
and is able to infect newly recruited M    . 
  The fi  ndings in this paper argue that inhibition of PGE  2   
comprises a mechanism specifi  c for virulent   Mtb  , a distinctly 
noninfl  ammatory role for this prostanoid in the regulated re-
sponse to this pathogen. Prostanoids, including PGE  2  , are the 
fi  nal product of the PGH synthases COX1 and 2. PGE  2   has 
been extensively studied and is well known for its role in me-
diating cardinal features of infl  ammation, including pain, vaso-
dilatation essential for the control of blood fl  ow, and leukocyte 
diapedesis leading to edema and fever (  34  ). We now show that 
the prostanoid PGE  2   protects against MPT and necrosis of 
M     infected with virulent   Mtb  . Our data are consistent with 
recently published fi  ndings in several other experimental sys-
tems that document an inhibitory role of PGE  2   in cell death. 
This mechanism is clearly complex and can be mediated in 
those studies either by the EP2 receptor (  57, 58  ) or the EP4 
receptor (  59  ). Although we defi  nitively confi  rm the role of 
PGE  2   and more precisely defi  ne its mechanistic activity by 
identifying EP2 as the crucial PGE  2   receptor, these fi  ndings 
beg for further dissection of this important signaling pathway 
leading to increased M     defense against   Mtb.   
  The mechanisms by which PGE  2   stimulates induction of 
apoptosis of   Mtb  -infected M     is not understood. Although 
PGE  2   stimulation of the EP4 receptor triggers activation of 
PI3K and of Akt (  48  ), blockade of mitochondrial damage by 
PGE  2   critical for prevention of necrosis is mediated through 
the EP2 receptor. The EP2 subtype couples to G protein       s   
and triggers intracellular cAMP formation. cAMP activates 
the PKA pathway (  45  ), which inhibits death in several cell 
types (  58  ). PKA activation was found to block cell death by 
phosphorylation of the proapoptotic protein Bad (  49, 50, 54  ), 
causing its inactivation, and also increases the expression of 
Bcl-2 involving the CREB (cAMP responsive element-bind-
ing) protein and inhibition of cell death (  59  ). At present, we 
do not know which of these mechanisms is involved in the 
mitochondrial inner membrane stabilization by PGE  2   and in 
the inhibition of LXA  4   production. 
  The innate immune system is the fi  rst line of defense 
against invading microbial pathogens and viruses (  60  ). Apop-
tosis characterized by intact plasma membranes, formation of 
apoptotic bodies and DNA fragmentation is an important 
component of the innate immune defense against   Mtb   and JEM VOL. 205, November 24, 2008 
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TTCAAATGAGATTGTGGGAAAATTGCT and AGATCATCTCTG-
CCTGAGTATCTT. Primer sequences for GAPDH were ACCACAG-
TCCATGCCATCAC and TCCACCACCCTGTTGCTGTA. 
  PI staining.     Adherent mPGES      /      spleen M         adherent were stained with 
2.5   μ  g/ml PI in RPMI containing 10% FBS at 4  °  C for 10 min and washed 
with ice-cold PBS and H  2  O. Dried and mounted coverslips were examined 
using a fl  uorescence microscope and photographed with a digital camera 
(DFC300; Leica). 
  siRNA transfection.     The 5-LO siRNA target sequence (AAATGCCA-
CAAGGATTTACCC) targeted against   NM_000698   and a scrambled con-
trol siRNA sequence (GCCCTCTATCGAATAAGACAA) designed with 
siRNA target fi  nder (Ambion) (  63  ) was used. The siRNAs were synthesized 
from DNA templates with the Silencer siRNA construction kit (Ambion) 
according to the manufacturer  ’  s instructions. Cells were cultured in IMDM 
with 10% human AB serum, and the medium was changed 1 d before trans-
fection. All siRNAs were used at a fi  nal concentration of 50 nM by diluting 
with Opti-MEM I reduced serum medium. To oligofectamine (1:200 dilu-
tion; Invitrogen), fresh IMDM containing 30% human AB serum (Gemini 
Bio-Products) was added to bring the serum concentration to 10%. After 72 
h of transfection at 37  °  C, the cells were infected with   Mtb  . To examine the 
eff  ect of siRNA transfection, cells were harvested and analyzed using North-
ern or Western blotting. 
  Statistics.     Results are expressed as mean   ±   SEM. The data were analyzed 
by using Excel Statistical Software (Microsoft) using the Student  ’  s   t   test for 
normally distributed data with equal variances. CFU were log  10   transformed 
and analyzed using the Mann Whitney nonparametric   t   test. A p-value   <  0.05 
was considered statistically signifi  cant. 
  Online supplemental material.     Fig. S1 shows sensitization of human M     
with 1 nM LXA  4  , 1 h before infection with H37Ra (MOI 10:1) to decreas-
ing concentrations of PGE  2  . Fig. S2 shows FACS analysis of necrotic cells 
(7-ADD) in human and murine M     cultures infected with MOI 10:1 and 
20:1 H37Rv and H37Ra for 72 h. 
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  Cells and culture.     Mononuclear cells from leukopacks of healthy donors 
or from mouse spleens (  7  ) were plated for FACS analysis at 4   ×   10   5   cells/ml/
well in 12-well cluster plates (Corning) and for PI staining and transfection 
with small interfering RNA (siRNA) at 5   ×   10  5   cells/ml/well in 12-well 
cluster plates. Human M     were cultured for 7 d in IMDM with 10% human 
AB serum (Gemini Bio-Products) and mouse spleen M     for 8  –  10 d in RPMI 
1640 (Invitrogen) with 10% fetal bovine serum (Gemini Bio-Products), 1% 
Hepes, 1% penicillin/streptomycin, and 0.1%   	  -mercaptoethanol. 
  In vitro infection of M    .     CD11b  +   cells were purifi  ed from thioglycollate 
(3%)-elicited peritoneal M     harvested from WT and PGES      /      mice by 
MACS column purifi  cation. The purity of the CD11b+ M     was 90%. 
CD11b+ M     (10  5  /well) were allowed to adhere in a 96-well culture plate 
for 24 h. Adherent cells were infected with virulent H37Rv (MOI 10: 1) for 
varying time periods. At diff  erent time points, cells were washed extensively 
with PBS and lysed in H  2  0 for 5 min, and mycobacterial growth was evalu-
ated by enumeration of the bacilli for 21 d by plating the cell lysates on Mid-
dlebrook 7H10 agar plates and incubating at 37  °  C. 
  Aerosol infection of mice.     C57BL/6 and mPGES-1      /      mice were in-
fected with virulent   Mtb   (Erdman strain) via the aerosol route using a nose-
only exposure unit (Intox Products) and received     100 CFU/mouse (  3, 15, 16  ). 
After 5 wk, mice were killed by CO  2   inhalation and the left lung was asepti-
cally removed and individually homogenized in 0.9% NaCl-0.02% Tween 
80 with a Mini-Bead Beater 8 (BioSpec Products, Inc.). Viable bacteria were 
enumerated by plating 10-fold serial dilutions of organ homogenates onto 
7H11 agar plates (Remel). Colonies were counted after 3 wk of incubation 
at 37  °  C. 
  LC-MS-MS and ELISA.     PGE  2  , PGF  2     , PGD  2  , and LXA  4   concentrations in 
cell supernatants were determined using ELISA kits (Oxford Biomedical Re-
search) according to the recommendations of the manufacturer. The TXA  2   
concentration was determined with the TXB  2   express EIA kit (Cayman 
Chemical). 50   μ  l of culture media from infected M     was added to wells in 
duplicate and absorbance was determined using a microplate reader. The lipid 
concentration was determined using standard curves. LXA  4   and PGE  2   identity 
were confi  rmed using LC-MS-MS diagnostic ions and their physical prop-
erties. For LC-MS-MS, an LCQ ion trap mass spectrometer (Finnigan Corp.) 
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